Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RUCAPARIB: 434 Adverse Event Reports & Safety Profile

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More
434
Total FAERS Reports
50 (11.5%)
Deaths Reported
310
Hospitalizations
434
As Primary/Secondary Suspect
43
Life-Threatening
8
Disabilities

First Report: 20140716 · Latest Report: 20250331

What Are the Most Common RUCAPARIB Side Effects?

#1 Most Reported
Anaemia
49 reports (11.3%)
#2 Most Reported
Acute kidney injury
34 reports (7.8%)
#3 Most Reported
Febrile neutropenia
33 reports (7.6%)

All RUCAPARIB Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Anaemia 49 11.3% 2 37
Acute kidney injury 34 7.8% 6 34
Febrile neutropenia 33 7.6% 2 33
Fatigue 32 7.4% 1 10
Nausea 30 6.9% 0 15
Pancytopenia 27 6.2% 2 24
Diarrhoea 23 5.3% 1 18
Drug ineffective 22 5.1% 6 1
Vomiting 20 4.6% 0 16
Abdominal pain 17 3.9% 0 15
Thrombocytopenia 17 3.9% 4 12
Constipation 15 3.5% 0 5
Malignant neoplasm progression 15 3.5% 8 6
Pyrexia 13 3.0% 0 11
Decreased appetite 12 2.8% 0 3
Dehydration 12 2.8% 0 10
Abdominal pain upper 11 2.5% 0 7
Pneumonia 11 2.5% 1 11
Sepsis 11 2.5% 3 11
Disease progression 10 2.3% 1 3

Who Reports RUCAPARIB Side Effects? Age & Gender Data

Gender: 69.5% female, 30.5% male. Average age: 64.3 years. Most reports from: US. View detailed demographics →

Is RUCAPARIB Getting Safer? Reports by Year

YearReportsDeathsHosp.
2014 3 0 2
2015 2 0 2
2016 15 6 13
2017 32 4 17
2018 58 5 47
2019 79 8 65
2020 119 8 105
2021 48 6 39
2022 17 3 9
2023 5 0 4
2025 2 0 0

View full timeline →

What Is RUCAPARIB Used For?

IndicationReports
Ovarian cancer 201
Prostate cancer metastatic 34
Small cell lung cancer 29
Hormone-refractory prostate cancer 27
Prostate cancer 27
Endometrial cancer 15
Neoplasm 13
Product used for unknown indication 12
Fallopian tube cancer 9
Neoplasm malignant 9

RUCAPARIB vs Alternatives: Which Is Safer?

RUCAPARIB vs RUCAPARIB CAMSYLATE RUCAPARIB vs RUFINAMIDE RUCAPARIB vs RUPATADINE RUCAPARIB vs RUXOLITINIB RUCAPARIB vs SABRIL RUCAPARIB vs SACCHAROMYCES CEREVISIAE RUCAPARIB vs SACITUZUMAB GOVITECAN RUCAPARIB vs SACITUZUMAB GOVITECAN-HZIY RUCAPARIB vs SACROSIDASE RUCAPARIB vs SACUBITRIL

Official FDA Label for RUCAPARIB

Official prescribing information from the FDA-approved drug label.